Generation Bio Co. (GBIO)

Jan 6, 2025, 4:30 PM EST - 11 days ago

Generation Bio to Apply ctLNP Delivery Technology to Develop siRNA Therapeutics for T Cell-Driven Autoimmune Diseases

Oct 22, 2024, 6:59 AM EDT - 3 months ago

Generation Bio Announces the Presentation of Preclinical Data on ctLNP and iqDNA at the ESGCT 31st Annual Congress

Sep 12, 2024, 4:05 PM EDT - 4 months ago

Generation Bio to Present at the 2024 Cantor Global Healthcare Conference

Aug 6, 2024, 6:59 AM EDT - 5 months ago

Generation Bio to Present at the Canaccord Genuity 44th Annual Growth Conference

Jun 14, 2024, 6:59 AM EDT - 7 months ago

Generation Bio to Present at the 2024 TD Cowen Genetic Medicines & RNA Summit

May 13, 2024, 4:05 PM EDT - 8 months ago

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

May 9, 2024, 6:59 AM EDT - 9 months ago

Generation Bio Announces the Presentation of Preclinical Data on iqDNA and ctLNP Platforms at the ASGCT 27th Annual Meeting

Apr 22, 2024, 5:31 PM EDT - 9 months ago

Generation Bio Announces the Acceptance of Five Abstracts and an Invited Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting

Apr 2, 2024, 6:59 AM EDT - 10 months ago

Generation Bio to Present at the 23rd Annual Needham Virtual Healthcare Conference

Mar 6, 2024, 4:20 PM EST - 11 months ago

Generation Bio Reports Business Highlights and Fourth Quarter and Full Year 2023 Financial Results

Feb 27, 2024, 6:59 AM EST - 11 months ago

Generation Bio to Present at the 2024 TD Cowen Health Care Conference

Jan 3, 2024, 4:05 PM EST - 1 year ago

Generation Bio to Present at the 42nd Annual J.P. Morgan Healthcare Conference

Nov 29, 2023, 6:59 AM EST - 1 year ago

Generation Bio Announces Strategic Reorganization to Extend Cash Runway for Development of ctLNP and iqDNA Platforms

Nov 9, 2023, 4:15 PM EST - 1 year ago

Generation Bio Reports Business Highlights and Third Quarter 2023 Financial Results

Oct 26, 2023, 6:59 AM EDT - 1 year ago

Generation Bio Announces Demonstration of Highly Selective T Cell Transduction In Vivo with Cell-Targeted LNP Platform

Oct 20, 2023, 8:15 AM EDT - 1 year ago

Top 4 Health Care Stocks That May Rocket Higher This Month - Generation Bio (NASDAQ:GBIO), Evelo Biosciences (NASDAQ:EVLO)

SPRB

Oct 18, 2023, 6:59 AM EDT - 1 year ago

Generation Bio Announces Breakthrough in its Non-Viral Genetic Medicine Platform with Novel “Immune-Quiet” DNA

Sep 19, 2023, 7:30 AM EDT - 1 year ago

Generation Bio to Present at the Jefferies Cell & Genetic Medicine Summit

Aug 3, 2023, 7:30 AM EDT - 1 year ago

Generation Bio to Present at the Canaccord Genuity 43rd Annual Growth Conference

Aug 2, 2023, 4:15 PM EDT - 1 year ago

Generation Bio Reports Second Quarter 2023 Financial Results

May 31, 2023, 7:30 AM EDT - 1 year ago

Generation Bio to Present at the 2023 Jefferies Healthcare Conference

May 10, 2023, 4:15 PM EDT - 1 year ago

Generation Bio Reports Business Highlights and First Quarter 2023 Financial Results

May 9, 2023, 4:15 PM EDT - 1 year ago

Generation Bio to Present at the JMP Securities Life Sciences Conference

Apr 11, 2023, 7:30 AM EDT - 1 year ago

Generation Bio to Present at the 22nd Annual Needham Virtual Healthcare Conference

Apr 5, 2023, 7:30 AM EDT - 1 year ago

Generation Bio Appoints Yalonda Howze, J.D. as Chief Legal Officer

Mar 23, 2023, 7:44 AM EDT - 1 year ago

Generation Bio, Moderna announce collaboration

MRNA

Mar 23, 2023, 7:02 AM EDT - 1 year ago

Moderna and Generation Bio Announce Strategic Collaboration to Develop Non-Viral Genetic Medicines

MRNA

Mar 21, 2023, 4:15 PM EDT - 1 year ago

Generation Bio to Participate in the BMO Biopharma Spotlight Series: Novel Technologies for the Delivery of Genetic Medicines

Feb 27, 2023, 7:30 AM EST - 2 years ago

Generation Bio to Present at the 43rd Annual Cowen Healthcare Conference

Feb 23, 2023, 4:28 PM EST - 2 years ago

Generation Bio Outlines 2023 Strategic Priorities and Reports Fourth Quarter and Full Year 2022 Financial Results

Jan 3, 2023, 4:30 PM EST - 2 years ago

Generation Bio to Present at the 41st Annual J.P. Morgan Healthcare Conference

Nov 3, 2022, 4:15 PM EDT - 2 years ago

Generation Bio Reports Business Highlights and Third Quarter 2022 Financial Results

Sep 22, 2022, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the 2022 Jefferies Cell and Genetic Medicine Summit

Sep 20, 2022, 7:30 AM EDT - 2 years ago

Generation Bio Names Phillip Samayoa, Ph.D. Chief Strategy Officer

Aug 4, 2022, 4:15 PM EDT - 2 years ago

Generation Bio Reports Business Highlights and Second Quarter 2022 Financial Results

Aug 2, 2022, 4:15 PM EDT - 2 years ago

Generation Bio to Present at the 2022 Wedbush PacGrow Healthcare Conference

Jul 18, 2022, 7:30 AM EDT - 2 years ago

Generation Bio Appoints Dannielle Appelhans to Its Board of Directors

Jun 2, 2022, 7:30 AM EDT - 2 years ago

Generation Bio to Present at the 2022 Jefferies Healthcare Conference

May 5, 2022, 4:15 PM EDT - 2 years ago

Generation Bio Reports Business Highlights and First Quarter 2022 Financial Results

Apr 5, 2022, 7:30 AM EDT - 3 years ago

Generation Bio to Participate in 21st Annual Needham Virtual Healthcare Conference

Mar 2, 2022, 7:30 AM EST - 3 years ago

Generation Bio to Participate in 42nd Annual Cowen Health Care Conference

Feb 24, 2022, 4:20 PM EST - 3 years ago

Generation Bio Outlines 2022 Strategic Priorities and Reports Fourth Quarter and Full Year 2021 Financial Results

Feb 10, 2022, 7:30 AM EST - 3 years ago

Generation Bio Promotes Antoinette Paone, M.S., MBA to Chief Operating Officer

Jan 5, 2022, 7:30 AM EST - 3 years ago

Generation Bio to Present at 40th Annual J.P. Morgan Healthcare Conference

Dec 14, 2021, 12:46 PM EST - 3 years ago

Generation Bio Hits 52-Week Low After Preclinical Data From Hemophilia A Program

Dec 14, 2021, 6:30 AM EST - 3 years ago

Generation Bio Provides Update on Preclinical Studies for Hemophilia A Program

Nov 10, 2021, 4:20 PM EST - 3 years ago

Generation Bio Reports Business Highlights and Third Quarter 2021 Financial Results

Oct 22, 2021, 7:30 AM EDT - 3 years ago

Generation Bio Presents Data Demonstrating First Lipid Nanoparticle to Achieve Uniform Retinal Transduction and Tolerability via Sub-Retinal Delivery of ceDNA and mRNA at the European Society of Gene and Cell Therapy 2021 Annual Virtual Congress